THE POZ PLATFORM Trademark

Trademark Overview

On Friday, October 9, 2015, a trademark application was filed for THE POZ PLATFORM with the United States Patent and Trademark Office. The USPTO has given the THE POZ PLATFORM trademark a serial number of 86783699. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 25, 2025. This trademark is owned by Serina Therapeutics, Inc.. The THE POZ PLATFORM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing research and development services for others in the design and synthesis of agents for attachment to surfaces and molecules in the biotechnical, biomedical and pharmaceutical industries for the treatment of neurological diseases, cancer, and pain
the poz platform

General Information

Serial Number86783699
Word MarkTHE POZ PLATFORM
Filing DateFriday, October 9, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 25, 2025
Registration Number5656069
Registration DateTuesday, January 15, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2016

Trademark Statements

NOT AVAILABLE"PLATFORM"
Goods and ServicesProviding research and development services for others in the design and synthesis of agents for attachment to surfaces and molecules in the biotechnical, biomedical and pharmaceutical industries for the treatment of neurological diseases, cancer, and pain

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, July 26, 2025
Primary Code042
First Use Anywhere DateThursday, November 1, 2018
First Use In Commerce DateThursday, November 1, 2018

Trademark Owner History

Party NameSERINA THERAPEUTICS (AL), INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressHUNTSVILLE, AL 35806
Party NameSerina Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHuntsville, AL 35806
Party NameSerina Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHuntsville, AL 35806
Party NameSerina Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHuntsville, AL 35806

Trademark Events

Event DateEvent Description
Thursday, October 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 1, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, October 13, 2015NEW APPLICATION ENTERED
Monday, February 1, 2016ASSIGNED TO EXAMINER
Monday, February 1, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, February 1, 2016EXAMINERS AMENDMENT E-MAILED
Monday, February 1, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 4, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, February 4, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, February 4, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, February 4, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Friday, February 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2016PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 5, 2017SOU EXTENSION 3 GRANTED
Tuesday, December 6, 2016SOU EXTENSION 1 FILED
Tuesday, December 6, 2016SOU EXTENSION 1 GRANTED
Thursday, December 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 5, 2017SOU TEAS EXTENSION RECEIVED
Monday, June 5, 2017SOU EXTENSION 2 FILED
Monday, June 5, 2017SOU EXTENSION 2 GRANTED
Wednesday, June 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2017SOU EXTENSION 3 FILED
Monday, June 4, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 4, 2018SOU TEAS EXTENSION RECEIVED
Monday, June 4, 2018SOU EXTENSION 4 FILED
Monday, June 4, 2018SOU EXTENSION 4 GRANTED
Monday, December 3, 2018USE AMENDMENT FILED
Thursday, December 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 3, 2018TEAS STATEMENT OF USE RECEIVED
Monday, December 3, 2018SOU TEAS EXTENSION RECEIVED
Monday, December 3, 2018SOU EXTENSION 5 FILED
Tuesday, December 11, 2018SOU EXTENSION 5 GRANTED
Tuesday, December 11, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 12, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 15, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, April 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 27, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 27, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 11, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 11, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 27, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 15, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 25, 2025CANCELLED SEC. 8 (6-YR)
Wednesday, April 10, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

platform industries pharmaceutical biomedical biotechnical treatment neurological pain cancer diseases molecules